Natera Net Income 2014-2024 | NTRA

Natera annual/quarterly net income history and growth rate from 2014 to 2024. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
  • Natera net income for the quarter ending December 31, 2024 was $-0.054B, a 31.09% decline year-over-year.
  • Natera net income for the twelve months ending December 31, 2024 was $-0.190B, a 56.2% decline year-over-year.
  • Natera annual net income for 2024 was $-0.19B, a 56.2% decline from 2023.
  • Natera annual net income for 2023 was $-0.435B, a 20.63% decline from 2022.
  • Natera annual net income for 2022 was $-0.548B, a 16.13% increase from 2021.
Natera Annual Net Income
(Millions of US $)
2024 $-190
2023 $-435
2022 $-548
2021 $-472
2020 $-230
2019 $-125
2018 $-128
2017 $-138
2016 $-100
2015 $-70
2014 $-5
2013 $-37
Natera Quarterly Net Income
(Millions of US $)
2024-12-31 $-54
2024-09-30 $-32
2024-06-30 $-37
2024-03-31 $-68
2023-12-31 $-78
2023-09-30 $-109
2023-06-30 $-111
2023-03-31 $-137
2022-12-31 $-143
2022-09-30 $-121
2022-06-30 $-145
2022-03-31 $-139
2021-12-31 $-141
2021-09-30 $-151
2021-06-30 $-116
2021-03-31 $-64
2020-12-31 $-76
2020-09-30 $-58
2020-06-30 $-60
2020-03-31 $-35
2019-12-31 $-35
2019-09-30 $-23
2019-06-30 $-32
2019-03-31 $-34
2018-12-31 $-32
2018-09-30 $-30
2018-06-30 $-34
2018-03-31 $-33
2017-12-31 $-47
2017-09-30 $-28
2017-06-30 $-29
2017-03-31 $-33
2016-12-31 $-42
2016-09-30 $-26
2016-06-30 $-23
2016-03-31 $-9
2015-12-31 $-23
2015-09-30 $-18
2015-06-30 $-20
2015-03-31 $-10
2014-12-31
2014-09-30 $0
2014-06-30 $-1
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical Services $20.836B $1.697B
Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $140.350B 26.32
Elevance Health (ELV) United States $91.117B 11.76
CVS Health (CVS) United States $79.102B 9.83
Cencora (COR) United States $56.251B 19.57
DiDi Global (DIDIY) China $21.979B 33.36
BioMerieux (BMXMF) France $15.355B 0.00
Solventum (SOLV) United States $12.822B 13.57
EUROFINS SCIENT (ERFSF) Luxembourg $12.604B 0.00
CochLear (CHEOY) Australia $11.282B 0.00
Revvity (RVTY) United States $10.993B 18.92
ICON (ICLR) Ireland $10.630B 9.88
Viatris (VTRS) United States $10.375B 3.56
Doximity (DOCS) United States $9.813B 45.70
Avantor (AVTR) United States $9.138B 13.28
Medpace Holdings (MEDP) United States $8.785B 23.33
HealthEquity (HQY) United States $8.497B 41.80
Sonic Healthcare (SKHHY) Australia $8.220B 0.00
Charles River Laboratories (CRL) United States $6.924B 13.57
Amplifon S.p.A (AMFPF) Italy $4.966B 26.21
BrightSpring Health Services (BTSG) United States $4.257B 39.40
Bausch + Lomb (BLCO) Canada $4.156B 24.50
Sotera Health (SHC) United States $3.633B 20.65
Alignment Healthcare (ALHC) United States $3.122B 0.00
Surgery Partners (SGRY) United States $3.068B 39.90
Concentras Parent (CON) United States $2.912B 16.83
Organon (OGN) United States $2.350B 2.50
Ardent Health Partners (ARDT) United States $2.204B 9.40
GeneDx Holdings (WGS) United States $1.949B 75.07
Progyny (PGNY) United States $1.912B 42.08
Premier (PINC) United States $1.904B 14.45
PACS (PACS) United States $1.647B 0.00
GoodRx Holdings (GDRX) United States $1.414B 28.29
Teladoc Health (TDOC) United States $1.319B 0.00
Pediatrix Medical (MD) United States $1.283B 9.76
Establishment Labs Holdings (ESTA) $1.046B 0.00
Agilon Health (AGL) United States $1.014B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.998B 0.00
CareDx (CDNA) United States $0.977B 15.25
Nutex Health (NUTX) United States $0.972B 14.69
AMN Healthcare Services Inc (AMN) United States $0.869B 8.13
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Embecta (EMBC) United States $0.702B 4.73
InnovAge Holding (INNV) United States $0.566B 0.00
Enhabit (EHAB) United States $0.539B 44.33
Auna S.A (AUNA) Luxembourg $0.514B 13.63
Sonida Senior Living (SNDA) United States $0.494B 0.00
LifeMD (LFMD) United States $0.487B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.370B 0.00
SBC Medicals (SBC) United States $0.352B 0.00
Oncology Institute (TOI) United States $0.226B 0.00
Beauty Health (SKIN) United States $0.218B 0.00
Performant Healthcare (PHLT) United States $0.209B 0.00
DocGo (DCGO) United States $0.150B 24.50
Sera Prognostics (SERA) United States $0.087B 0.00
So-Young (SY) China $0.084B 0.00
OncoCyte (OCX) United States $0.080B 0.00
KindlyMD (KDLY) United States $0.078B 0.00
Ascend Wellness Holdings (AAWH) United States $0.065B 0.00
NeueHealth (NEUE) United States $0.062B 0.00
IceCure Medical (ICCM) Israel $0.058B 0.00
Biodesix (BDSX) United States $0.044B 0.00
Basel Medical Group (BMGL) Singapore $0.044B 0.00
Pheton Holdings (PTHL) China $0.036B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.033B 0.00
ModivCare (MODV) United States $0.013B 0.00
SeaStar Medical Holding (ICU) United States $0.013B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
Intelligent Bio Solutions (INBS) United States $0.008B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00